111 results on '"Hessmann E"'
Search Results
2. Machine Learning Pipeline for predicting Overall Survival Status and Survival Months in Pancreatic Cancer
3. Framework for Federated Artificial Intelligence for the Optimization of Pancreatic Cancer Treatment
4. FAIR data management in clinical research. Integrating patient and genomic cancer data with cBioPortal
5. Epigenetische Strategien in der Krebstherapie
6. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
7. Epigenetische Strategien in der Krebstherapie
8. NFATc1 as a therapeutic target in FLT3-ITD-positive AML
9. Signaling and Chromatin Networks in Cancer Biology
10. Inhibition of STAT-3 sensitizes pancreatic cancer cells to chemoradiotherapy
11. Uncovering an epigenetically-regulated basal A Subtype-specific Transcribed Enhancer Program (B-STEP) in aggressive pancreatic ductal adenocarcinoma
12. EZH2, an epigenetic factor involved in oncogenic properties of ATM deficient PDAC subtypes?
13. Making use of synergistic targeting to treat DNA damage repair deficient pancreatic cancer
14. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
15. Die Regulation von DNA-Reparaturmechanismen unter der Kontrolle von GSK3ß in der Pankreaskarzinomtherapie
16. Kombinierte Radiochemotherapeutika zur Behandlung von endogenen Pankreaskarzinomen im KPC-Modell – eine feasibility Studie
17. Chapter 13 - Signaling and Chromatin Networks in Cancer Biology
18. GSK3ß als Regulator der Chromatinplastizität in der Pankreaskarzinomtherapie
19. Etablierung neuer Therapiestrategien beim ATM defizienten Pankreaskarzinom
20. ATM-Defizienz führt zu genomischer Instabilität im duktalen Pankreaskarzinom und sensibilisiert für neue Therapieoptionen
21. Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer
22. Gemcitabine uptake and metabolism of cancer associated fibroblasts in murine pancreatic cancer
23. Charakterisierung von NFATc1/Smad3-Komplexen im Smad4-defizienten Pankreaskarzinom
24. EZH2-abhängige posttranskriptionelle Regulation der NFATc1-Expression im kolorektalen Karzinom
25. Nuclear transcription complexes mediate inflammation-associated pancreatic carcinogenesis
26. Interplay of oncogenic transcription programs and tumor suppressor modules regulates EMT and stemnes in pancreatic carcinogenesis
27. Epigenetische Strategien in der Krebstherapie
28. KDM 7a antagonosiert G9a kontrollierte Histonmodifikationen in der Regulation von Makroautophagie
29. LC-MS/MS analysis of gemcitabine and its metabolites in primary murine pancreatic tumors and liver metastases
30. Distinct temporal regulation of NFATc1 activity safeguards proper regeneration of the exocrine pancreas
31. The influence of NFATc1 on the inflammatory tumor environment in pancreatic carcinogenesis
32. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies
33. Electron Transfer-Based Compounds: A Novel Weapon in the Cancer Battlespace?
34. NFATc1 cooperation with EZH2 hastens oncogenic activity in pancreatic cancer
35. NFATc1 -EGFR loop controls Sox9 promoter for Acinar ductal metaplasia
36. Antithetical NFATc1-Sox2 and p53-miR-200 signalling networks governs pancreatic cancer cell plasticity and tumour progression
37. The influence of NFATc1 on the inflammatory tumor environment in pancreatic carcinogenesis
38. Regeneration from acute pancreatitis requires transcriptional silencing of NFATc1
39. Regeneration from acute pancreatitis requires transcriptional silencing of NFATc1
40. KRAS G 12C -inhibitor-based combination therapies for pancreatic cancer: insights from drug screening.
41. A Concept for Mining Transitive Sequential Patterns from Pancreatic Cancer Patient Journeys.
42. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction.
43. Author Correction: Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma.
44. Expression of gemcitabine metabolizing enzymes and stromal components reveal complexities of preclinical pancreatic cancer models for therapeutic testing.
45. A single-cell strategy for the identification of intronic variants related to mis-splicing in pancreatic cancer.
46. An NFATc1/SMAD3/cJUN Complex Restricted to SMAD4-Deficient Pancreatic Cancer Guides Rational Therapies.
47. Epigenetic control of pancreatic cancer metastasis.
48. Identification of a ΔNp63-Dependent Basal-Like A Subtype-Specific Transcribed Enhancer Program (B-STEP) in Aggressive Pancreatic Ductal Adenocarcinoma.
49. Interactive enhancer hubs (iHUBs) mediate transcriptional reprogramming and adaptive resistance in pancreatic cancer.
50. NFATc1 Is a Central Mediator of EGFR-Induced ARID1A Chromatin Dissociation During Acinar Cell Reprogramming.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.